- epiq Animal Health and Vetirus Animal Health have signed a U.S. distribution and strategy agreement.
- The partnership centers on Rebound™ High Performance PRP, a regenerative medicine platform for companion animals and horses.
- Rebound PRP is designed to support healing, reduce inflammation, and promote tissue regeneration without specialized equipment.
- The companies will collaborate on product distribution, education, and training initiatives for veterinary professionals.
- The product is currently available through animal health distribution channels.
epiq Animal Health and Vetirus Animal Health have announced a strategic partnership designed to expand veterinarian access to regenerative medicine solutions across the United States.
Under the agreement, epiq Animal Health will serve as the exclusive U.S. distributor for Vetirus Animal Health’s Rebound™ High Performance PRP platform, a platelet-rich plasma (PRP) technology developed to support tissue healing and recovery in veterinary patients.
Expanding Regenerative Care Options
Vetirus has focused its research and development efforts on advancing companion animal healthcare through innovations in oncology, immunology, and regenerative medicine. Its flagship Rebound PRP platform is designed to provide veterinarians with a practical and cost-effective regenerative therapy option that does not require dedicated capital equipment.
The platform utilizes concentrated autologous platelet-rich plasma to help accelerate healing, reduce inflammation, and support tissue regeneration in a variety of orthopedic conditions.
“We are thrilled to partner with epiq Animal Health as our exclusive U.S. distributor,” said Robert N. Jordan, chief executive officer of Vetirus Animal Health. “epiq’s unmatched reach, technical expertise, and commitment to advancing veterinary medicine make them the ideal partner to scale Rebound PRP.”
Jordan said the collaboration will focus on providing veterinarians with clinical evidence, educational resources, and reliable product availability to support broader integration of regenerative therapies into everyday practice.
Education and Distribution Focus
In addition to expanding product availability, the companies plan to collaborate on training and educational programs designed to increase awareness and understanding of regenerative medicine applications among veterinary professionals.
According to Vetirus, Rebound PRP has demonstrated clinical utility in supporting recovery from orthopedic injuries and conditions including osteoarthritis, tendon and ligament injuries, partial cruciate ligament tears, and post-surgical healing.
The product is available in species-specific formats for both canine and equine patients and is currently offered through established animal health distribution channels.
The partnership aligns with epiq Animal Health’s mission of helping veterinary professionals gain access to innovative, science-backed products through strategic manufacturer and distributor relationships.
Information sourced from the company’s press release.
